Manage Patients Admitted on Rimegepant for Migraine Prophylaxis

You may see rimegepant (Nurtec ODT) on med lists for migraine PREVENTION in adults.

It blocks receptors of calcitonin gene-related peptide (CGRP), a vasodilator and pain sensitizer that spikes during migraine attacks.

Until recently, rimegepant was only approved for acute treatment. And only the INJECTABLE CGRP antagonists, such as erenumab (Aimovig), were approved for prevention.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals